Zimmer Biomet enters $1.5B five-year and $1.0B 364-day revolving credit facilities

ZIMMER BIOMET HOLDINGS, INC.

New $1.5B five-year unsecured revolving credit facility matures August 19, 2027, with two one-year extension options.
New $1.0B 364-day unsecured revolving credit facility matures August 18, 2023; both for general corporate purposes.
Prior 2021 five-year and 364-day credit agreements terminated; no borrowings were outstanding at termination.
Five-year facility has an uncommitted incremental feature allowing up to $500M additional capacity.
Interest based on adjusted Term SOFR plus margin determined by credit rating; leverage covenant max 4.5x EBITDA (5.0x for material acquisitions).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.